Pharmacokinetics (PK) of Nelfinavir (NFV) and its Active Metabolite (M8) in Very Young Infants Infected with Human Immunodeficiency Virus (HIV)
18 Apr, 2001
Authors: Litalien C, Faye A, Compagnucci A, Jacqz-Aigrain E. Published in: Pediatric Academic Societies 2001 Annual Meeting, April 28th – May 1st 2001, Baltimore MD. Abstract 2609.
Read More
Evolution of drug resistance in antiretroviral therapy-naïve children in PENTA 5
18 Apr, 2001
Authors: Loveday. C., Walker. A.S., Gibb. D.M., on behalf of the PENTA virology Group Published in: Fifth International Workshop on HIV Drug Resistance and Treatment Strategies, 2001, Scottsdale, USA. Abstract …
Read More
T cell repopulation in HIV infected children on highly active anti-retroviral therapy (HAART)
18 Apr, 2001
Authors: King D J.S., Gotch F M., Larsson-Sciard E. Published in: Clin Exp Immunol.2001;125(3):447-454 Abstract In this pilot study, we address the nature of the re-population of the T-cell compartment…
Read More
Evaluation of Toxicity, Tolerability and Antiviral Activity of Early d4T+ddI+Nelfinavir (NFV) Therapy in HIV-1 Vertically Infected Infants : 24 Week Preliminary Results from the PENTA 7 Study
18 Feb, 2001
Authors: Faye A , Compagnucci A., Saidi Y; for the PENTA 7 Executive Committee Published in: 8th Conference on Retroviruses and Opportunistic Infections, February 4th-8th, 2001, Chicago. Poster 678
Read More
Nelfinavir doses should be increased in infants less than 3 months
18 Jul, 2000
Authors: Litalien C. Giaquinto C. Faye A. Mechinaud F. Grosch I. Compagnucci A. Jacqz-Aigrain E. Published in: XIII International AIDS Conference July 9th-14th 2000, Durban, South Africa. Abstract Mo PEB 2213…
Read More
Current evidence for the use of pediatric antiretroviral therapy – a PENTA analysis
19 Apr, 2000
Authors: Sharland M, Gibb DM, Giaquinto C. Published in: European Journal of Pediatrics 2000; 159:649-656.
Read More
Variable use of therpaeutic interventions for children with human immunodeficiency virus type 1 infection in Europe.
19 Apr, 2000
Authors: Bernardi S, Thorne C, Newell ML, Giaquinto C,Tovo PA, Rossi P. Published in: European Journal of Pediatrics 2000; 159(3):170-5
Read More
Reconstitution of the T-cell Pool in Treated, HIV-infected Children
18 Apr, 2000
Authors: King D, Gibb DM, Gotch F, Larsson-Sciard E. Published in: 7th Conference on Retroviruses and Opportunistic Infections, January 30th- February 2nd, 2000, Abstract 322., San Francisco. Abstract 322
Read More
Immune repopulation after HAART in previously untreated HIV-1 infected children
18 Apr, 2000
Authors: Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Wörner I, Babiker A Published in: Lancet.2000; 355: 1331-2 Abstract In 25 vertically HIV-infected children receiving highly-active antiretroviral therapy, a…
Read More
A randomised trial evaluating three NRTI regimens with and without Nelfinavir in HIV-infected children: 48 week follow-up from the PENTA 5 trial
18 Apr, 2000
Authors: Gibb. D. M. for the PENTA 5 Executive and the PENTA Steering Committee. Published in: Oral presentation at 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000 also published…
Read More
Drug resistance in a trial of nucleoside analogue and protease inhibitor therapy in children (PENTA 5)
18 Apr, 2000
Authors: Kaye S. on behalf of the PENTA Virology Committee. Published in: 5th International Congress on Drug Therapy in HIV Infection, October 22nd-26th 2000, Glasgow. P_308.
Read More
Parents’ attitudes to their HIV-infected children being enrolled into a placebo-controlled trial: the PENTA 1 trial. Paediatric European Network for Treatment of AIDS
01 Oct, 1999
Authors: Paediatric European Network for Treatment of AIDS (PENTA) Published in: HIV Med. 1999;1(1):25-31 Objective The study aimed to explore the experience of parents/care-givers to their child’s participation in a European randomized trial of immediate…
Read More
Plasma viral load and genotypic resistance patterns in children adding lamivudine to current reverse transcriptase inhibitor therapy (PENTA 4 Trial)
18 Apr, 1998
Authors: Kaye S, Loveday C, Gibb DM., Newberry A. Published in: 4th International Congress, November 8ht-12th 1998, Glasgow. P_305
Read More
A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial
12 Apr, 1998
Authors: Aboulker JP, Babiker A, Carrière I, et al. Published in: AIDS.1998;12(14):F151-F160 Objective To evaluate the toxicity, tolerability and effect on laboratory markers of adding lamivudine (3TC) to nucleoside analogue…
Read More
HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA)
05 Mar, 1998
Authors: Paediatric European Network for Treatment of AIDS (PENTA) Published in: AIDS. 1998;12(4):F1-8 Background Plasma HIV-1 RNA levels are high in vertically infected infants. Information in older children is limited, particularly in those who have not received…
Read More
The safety and tolerability of zidovudine (ZDV) and zalcitabine (ddC) in children with symptomatic HIV infection – PENTA 3
18 Oct, 1997
Authors: Gibb DM, Carrière I, Giaquinto C, Martinez M for PENTA Published in: VIth European Conference on Clinical Aspects and Treatment of HIV-Infection, 1997, October 1st-15th, Hamburg, Germany
Read More
Paediatric European Network for treatment of AIDS (PENTA).
19 Jul, 1996
Authors: Published in: XIth International Conference on AIDS, Vancouver, Canada 7 – 12 July, 1996.
Read More
Paediatric European Network for treatment of AIDS (PENTA).
19 Nov, 1994
Authors: Published in: 2nd International Congress on Drug Therapy in HIV Infection, Glasgow, UK 19-22 November, 1994.
Read More